These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 683013)

  • 1. Diabetogenic action of somatostatin in healthy subjects: effect of amino acids and somatostatin upon blood glucose, serum insulin, and glucagon.
    Waldhäusl WK; Bratusch-Marrain P; Loebenstein B
    Metabolism; 1978 Sep; 27(9 Suppl 1):1437-40. PubMed ID: 683013
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetogenic effects of somatostatin in maturity-onset diabetes and normal man: primacy of insulin deficiency rather than glucagon excess in the pathogenesis of diabetes.
    Sherwin RS; Tamborlane WV; Hendler R; Felig P
    Metabolism; 1978 Sep; 27(9 Suppl 1):1433-6. PubMed ID: 683012
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic effects of long-term somatostatin infusion in man.
    Gerich JE
    Metabolism; 1976 Nov; 25(11 Suppl 1):1505-7. PubMed ID: 988466
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C; Beck B; Kolopp M; Toussain P; Debry G
    Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amino acids on glucose disposal.
    Boden G; Tappy L
    Diabetes; 1990 Sep; 39(9):1079-84. PubMed ID: 1974539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog.
    Lien EL; Fenichel RL; Grant NH; Boxill GC; Greenwood J; Yardley JP
    Biochem Biophys Res Commun; 1977 Aug; 77(4):1317-25. PubMed ID: 143285
    [No Abstract]   [Full Text] [Related]  

  • 7. Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation.
    Raptis S; Escobar-Jimenez F; Rosenthal J; Ditschuneit HH; Pfeiffer EF
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1088-93. PubMed ID: 874045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
    Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
    J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evanescent effects of hypo- and hyperglucagonemia on blood glucose homeostasis.
    Sherwin R; Wahren J; Felig P
    Metabolism; 1976 Nov; 25(11 Suppl 1):1381-3. PubMed ID: 979638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid modulation of glucose-induced insulin and glucagon release in diabetic patients.
    Seino Y; Ikeda M; Nakane K; Nakahara H; Seino S
    Metabolism; 1977 Aug; 26(8):911-9. PubMed ID: 875735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM.
    Caprio S; Tamborlane WV; Zych K; Gerow K; Sherwin RS
    Diabetes; 1993 Apr; 42(4):550-5. PubMed ID: 8454105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients.
    Tsai AC; Vinik AI; Lasichak A; Lo GS
    Am J Clin Nutr; 1987 Mar; 45(3):596-601. PubMed ID: 2881482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
    Ward FR; Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics.
    Christensen SE; Hansen AP; Weeke J; Lundbaek K
    Diabetes; 1978 Mar; 27(3):300-6. PubMed ID: 640235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of streptozotocin on insulin and glucagon responses of rat islets.
    Katsilambros N; Rahman YA; Hinz M; Fussgänger R; Schröder KE; Straub K; Pfeiffer EF
    Horm Metab Res; 1970 Sep; 2(5):268-70. PubMed ID: 4258677
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of somatostatin in maturity-onset diabetes.
    Tamborlane WV; Sherwin RS; Hendler R; Felig P
    N Engl J Med; 1977 Jul; 297(4):181-3. PubMed ID: 876274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of somatostatin in the study of carbohydrate homeostasis in man: physiologic, pathologic, and therapeutic considerations.
    Gerich JE
    Adv Exp Med Biol; 1977; 87():299-318. PubMed ID: 143198
    [No Abstract]   [Full Text] [Related]  

  • 20. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.
    Waldhäusl W; Bratusch-Marrain P; Nowotny P
    Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.